Trial Outcomes & Findings for A Comparison of the Success Rate Of Cannulation Between The Accuvein Apparatus And Standard Technique (NCT NCT01042613)

NCT ID: NCT01042613

Last Updated: 2011-12-07

Results Overview

This study will compare the first attempt success rate of cannulation in research participants randomized to using a new FDA approved AccuVein AV300 device for intravenous access with research participants randomized to standard cannulation methods. There is one timepoint for outcome data collection and it is prior to cannulation. Success (yes) is defined as needle insertion into target vein.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

146 participants

Primary outcome timeframe

At cannulation

Results posted on

2011-12-07

Participant Flow

148 total patients were recruited at single institution (SJCRH) study between Jan 13, 2010, and March 03, 2011.

148 total patients were enrolled on the study. The report is based on results for 146 patients. Two patients were excluded from this study. One patient was excluded due to MD's decision and the other patient was deemed to be inevaluable after study enrollment (cannula gauge other than 22 were used).

Participant milestones

Participant milestones
Measure
ACVein
Research participants are randomly assigned into group A (Accuvein AV300 assisted intravenous catheter insertion)
Standard
(standard technique of insertion of the intravenous cannula)
Overall Study
STARTED
72
74
Overall Study
COMPLETED
72
74
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

A Comparison of the Success Rate Of Cannulation Between The Accuvein Apparatus And Standard Technique

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
ACVein
n=72 Participants
Research participants are randomly assigned into group A (Accuvein AV300 assisted intravenous catheter insertion)
Standard
n=74 Participants
(standard technique of insertion of the intravenous cannula)
Total
n=146 Participants
Total of all reporting groups
Age Continuous
5.72 years
STANDARD_DEVIATION 3.72 • n=5 Participants
5.37 years
STANDARD_DEVIATION 3.88 • n=7 Participants
5.54 years
STANDARD_DEVIATION 3.79 • n=5 Participants
Sex: Female, Male
Female
35 Participants
n=5 Participants
43 Participants
n=7 Participants
78 Participants
n=5 Participants
Sex: Female, Male
Male
37 Participants
n=5 Participants
31 Participants
n=7 Participants
68 Participants
n=5 Participants

PRIMARY outcome

Timeframe: At cannulation

Population: Patients (age 17 years or less) undergoing elective surgery or examination under anesthesia who do not have existing intravenous access.

This study will compare the first attempt success rate of cannulation in research participants randomized to using a new FDA approved AccuVein AV300 device for intravenous access with research participants randomized to standard cannulation methods. There is one timepoint for outcome data collection and it is prior to cannulation. Success (yes) is defined as needle insertion into target vein.

Outcome measures

Outcome measures
Measure
ACVein
n=72 Participants
Research participants are randomly assigned into group A (Accuvein AV300 assisted intravenous catheter insertion)
Standard
n=74 Participants
(standard technique of insertion of the intravenous cannula)
First Attempt Success Rate of Cannulation
Successful first attempt
54 Participants
54 Participants
First Attempt Success Rate of Cannulation
Unsuccessful first attempt
18 Participants
20 Participants

SECONDARY outcome

Timeframe: At cannulation

Population: Of the 146 patients, two patients were excluded due to missing time records.

To assess if insertion of intravenous cannula is faster when intravenous access is assisted by the AccuVein AV 300 device as compared to the standard technique

Outcome measures

Outcome measures
Measure
ACVein
n=71 Participants
Research participants are randomly assigned into group A (Accuvein AV300 assisted intravenous catheter insertion)
Standard
n=73 Participants
(standard technique of insertion of the intravenous cannula)
Time Between Tourniquet Application and Successful Cannulation is Achieved or 4 Attempts Have Been Made (in Minutes).
1.48 Minutes
Standard Deviation .97
1.26 Minutes
Standard Deviation .84

SECONDARY outcome

Timeframe: At cannulation

To assess if the number of skin punctures is fewer when intravenous access is assisted by the AccuVein AV300 device as compared to the standard technique

Outcome measures

Outcome measures
Measure
ACVein
n=72 Participants
Research participants are randomly assigned into group A (Accuvein AV300 assisted intravenous catheter insertion)
Standard
n=74 Participants
(standard technique of insertion of the intravenous cannula)
Number of Skin Punctures
1.33 Skin punctures
Standard Deviation .75
1.26 Skin punctures
Standard Deviation .62

Adverse Events

ACVein

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Standard

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Luis Trujillo Huaccho, MD

St. Jude Children's Research Hospital

Phone: 1-866-278-5833

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place